Store Brands 2012: Drug Interactions

Pharmacy chains consolidate and refine lines to build loyalty and front-end profits

Walgreens is on track to double its private-label sales to $8 billion within the next five to seven years.

“It’s at the top of our list to grow private brands,” Laura Sturdevant, Walgreens’ director of product development, private brands, said at the annual Private Label Manufacturers Association’s trade show, held in Chicago in November.

(This article is part of SN's "Store Brands 2012: State of the Industry Report," which examines trends in priv

Register to view the full article

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.